4
May 2026
People share incomplete details with AI in symptom reports
It is quite possible that in the near future, people will have to describe their symptoms to an AI before they can get a doctor's appointment.
Stay Informed!
4
May 2026
Global MS initiative opens applications for research data access
The International Progressive MS Alliance announces the MS Clinical and Imaging Data Resource (MS CIDR) is now accepting applications for data access.
4
May 2026
Disruptions threaten progress in inclusive clinical trials and health equity
JMIR Publications today featured a critical new story in its News and Perspectives section examining the recent waves of disruption to inclusive clinical trials and the emerging strategies to keep health equity on track.
4
May 2026
Study finds weak penalties for Medicare Advantage rule violations
A new study from health policy researchers at the Brown University School of Public Health suggests that while regulators have several tools at their disposal to penalize insurance plans that break the rules, they rely mostly on relatively small financial penalties that may do little to deter violations.
4
May 2026
ASPIRE trial explores survival benefits of adding chemotherapy to standard prostate cancer treatment
The Alliance for Clinical Trials in Oncology is now enrolling patients in the ASPIRE trial (A032302)-a large-scale, phase III clinical study investigating whether adding chemotherapy to current standard treatments extends survival for men with advanced prostate cancer.
4
May 2026
Brain pathways shape distinct itch responses in the face and body
In a new study, researchers from North Carolina State University show that itch sensations in the face are perceived differently from those in the body due to differences in signaling between trigeminal (located in the brain) and spinal pain pathways.
4
May 2026
Study uncovers overlooked crisis of paternal deaths after childbirth
It took the better part of a century for maternal mortality to be recognized, forgotten and finally recognized again as an urgent public health crisis in the United States.
4
May 2026
Study highlights stigma surrounding popular GLP-1 weight loss drugs
Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss.
4
May 2026
Single low-dose atropine drop shows daylong effects for myopia
Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults.
4
May 2026
Study reveals gaps in dementia care services across Mississippi counties
Some 80% of Mississippi counties have no adult day service centers, and even counties that do have centers cannot meet the needs of people with dementia and their caregivers, a new University of Mississippi-led study indicates.
